Krilogy Financial LLC Grows Position in CVS Health Co. (NYSE:CVS)

Krilogy Financial LLC increased its position in shares of CVS Health Co. (NYSE:CVSGet Rating) by 1.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,075 shares of the pharmacy operator’s stock after purchasing an additional 108 shares during the period. Krilogy Financial LLC’s holdings in CVS Health were worth $841,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Macroview Investment Management LLC lifted its holdings in CVS Health by 128.3% during the 1st quarter. Macroview Investment Management LLC now owns 242 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 136 shares in the last quarter. Claremont Financial Group Inc. bought a new stake in shares of CVS Health in the 4th quarter valued at about $26,000. Stuart Chaussee & Associates Inc. raised its holdings in shares of CVS Health by 123.0% in the 1st quarter. Stuart Chaussee & Associates Inc. now owns 310 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 171 shares in the last quarter. Rise Advisors LLC bought a new stake in shares of CVS Health in the 4th quarter valued at about $41,000. Finally, Carl Stuart Investment Advisor Inc. bought a new stake in shares of CVS Health in the 1st quarter valued at about $41,000. Institutional investors own 77.64% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft boosted their price target on shares of CVS Health from $113.00 to $120.00 in a report on Thursday, August 4th. Sanford C. Bernstein downgraded shares of CVS Health from an “outperform” rating to a “market perform” rating and dropped their target price for the stock from $122.00 to $112.00 in a research report on Thursday, May 26th. Mizuho boosted their target price on shares of CVS Health from $115.00 to $120.00 and gave the stock a “buy” rating in a research report on Monday, August 15th. Tigress Financial upped their price objective on shares of CVS Health from $125.00 to $130.00 in a report on Wednesday, August 17th. Finally, UBS Group boosted their target price on shares of CVS Health from $118.00 to $127.00 and gave the company a “buy” rating in a research note on Thursday, August 4th. Four equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $117.59.

Insiders Place Their Bets

In other news, EVP Thomas M. Moriarty sold 138,654 shares of the stock in a transaction dated Tuesday, June 28th. The shares were sold at an average price of $95.00, for a total transaction of $13,172,130.00. Following the sale, the executive vice president now owns 626,273 shares of the company’s stock, valued at $59,495,935. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP Alan Lotvin sold 22,541 shares of the stock in a transaction dated Thursday, August 4th. The shares were sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the sale, the executive vice president now owns 109,183 shares of the company’s stock, valued at $11,355,032. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Thomas M. Moriarty sold 138,654 shares of the stock in a transaction dated Tuesday, June 28th. The stock was sold at an average price of $95.00, for a total transaction of $13,172,130.00. Following the sale, the executive vice president now directly owns 626,273 shares in the company, valued at approximately $59,495,935. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by insiders.

CVS Health Trading Up 0.1 %

Shares of CVS stock opened at $99.83 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.91 and a quick ratio of 0.65. The firm has a market cap of $131.06 billion, a PE ratio of 16.23, a price-to-earnings-growth ratio of 1.52 and a beta of 0.73. The company has a 50-day moving average of $100.14 and a two-hundred day moving average of $99.28. CVS Health Co. has a 1-year low of $81.78 and a 1-year high of $111.25.

CVS Health (NYSE:CVSGet Rating) last announced its earnings results on Wednesday, August 3rd. The pharmacy operator reported $2.40 earnings per share for the quarter, topping the consensus estimate of $2.16 by $0.24. The company had revenue of $80.64 billion during the quarter, compared to analyst estimates of $76.38 billion. CVS Health had a net margin of 2.65% and a return on equity of 15.19%. CVS Health’s revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the firm posted $2.42 earnings per share. On average, analysts predict that CVS Health Co. will post 8.53 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, November 1st. Shareholders of record on Friday, October 21st will be paid a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 2.20%. CVS Health’s dividend payout ratio (DPR) is presently 35.77%.

CVS Health Profile

(Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Featured Articles

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.